Dixon S - Search Results

1

The role of patient preferences in cost-effectiveness analysis: a conflict of values?

Brazier JE, Dixon S, Ratcliffe J. Brazier JE, et al. Among authors: dixon s. Pharmacoeconomics. 2009;27(9):705-12. doi: 10.2165/11314840-000000000-00000. Pharmacoeconomics. 2009. PMID: 19757864 Review.

2

The use of condition specific outcome measures in economic appraisal.

Brazier J, Dixon S. Brazier J, et al. Among authors: dixon s. Health Econ. 1995 Jul-Aug;4(4):255-64. doi: 10.1002/hec.4730040402. Health Econ. 1995. PMID: 8528428 Review.

3

Cost effectiveness of community leg ulcer clinics: randomised controlled trial.

Morrell CJ, Walters SJ, Dixon S, Collins KA, Brereton LM, Peters J, Brooker CG. Morrell CJ, et al. Among authors: dixon s. BMJ. 1998 May 16;316(7143):1487-91. doi: 10.1136/bmj.316.7143.1487. BMJ. 1998. PMID: 9582132 Free PMC article. Clinical Trial.

4

Improving the validity of economic evaluations alongside controlled trials.

Dixon S, Deverill M, Gannon M, Brazier J, Haggard M. Dixon S, et al. J Health Serv Res Policy. 1999 Jul;4(3):161-3. doi: 10.1177/135581969900400307. J Health Serv Res Policy. 1999. PMID: 10538881 No abstract available.

5

Testing the validity of cost-effectiveness models.

McCabe C, Dixon S. McCabe C, et al. Among authors: dixon s. Pharmacoeconomics. 2000 May;17(5):501-13. doi: 10.2165/00019053-200017050-00007. Pharmacoeconomics. 2000. PMID: 10977390 Review.

6

Economic evaluations of treatments for systemic fungal infections: a systematic review of the literature.

Dixon S, McKeen E, Tabberer M, Paisley S. Dixon S, et al. Pharmacoeconomics. 2004;22(7):421-33. doi: 10.2165/00019053-200422070-00002. Pharmacoeconomics. 2004. PMID: 15137881 Review.

7

Incorporating carer effects into economic evaluation.

Dixon S, Walker M, Salek S. Dixon S, et al. Pharmacoeconomics. 2006;24(1):43-53. doi: 10.2165/00019053-200624010-00004. Pharmacoeconomics. 2006. PMID: 16445302

8

Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK.

McEwan P, Dixon S, Baboolal K, Conway P, Currie CJ. McEwan P, et al. Among authors: dixon s. Pharmacoeconomics. 2006;24(1):67-79. doi: 10.2165/00019053-200624010-00006. Pharmacoeconomics. 2006. PMID: 16445304

9

Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomised trial.

Dixon S, Walters SJ, Turner L, Hancock BW. Dixon S, et al. Br J Cancer. 2006 Feb 27;94(4):492-8. doi: 10.1038/sj.bjc.6602973. Br J Cancer. 2006. PMID: 16449995 Free PMC article. Clinical Trial.

10

Cost-effectiveness analysis of different embryo transfer strategies in England.

Dixon S, Faghih Nasiri F, Ledger WL, Lenton EA, Duenas A, Sutcliffe P, Chilcott JB. Dixon S, et al. BJOG. 2008 May;115(6):758-66. doi: 10.1111/j.1471-0528.2008.01667.x. Epub 2008 Mar 19. BJOG. 2008. PMID: 18355368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,514 results

Search Page

Filters